{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T03:07:42Z","timestamp":1777777662671,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["Grant No. 2024YFC2310604"],"award-info":[{"award-number":["Grant No. 2024YFC2310604"]}]},{"name":"Shenzhen Science and Technology Program","award":["Grant No. ZDSYS20230626091203007"],"award-info":[{"award-number":["Grant No. ZDSYS20230626091203007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40121-026-01331-6","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:19:08Z","timestamp":1774531148000},"page":"1369-1384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact and Effectiveness of a Two-Dose Varicella Immunization Program Among School Children: Evidence from Quasi-experimental Analyses"],"prefix":"10.1007","volume":"15","author":[{"given":"Huiqiao","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuying","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuantian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaure","family":"Akhmetova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zarina","family":"Shulgau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0498-0662","authenticated-orcid":false,"given":"Yawen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"6","key":"1331_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70458","volume":"97","author":"Z Shen","year":"2025","unstructured":"Shen Z, Song Q, Zhang G, Xin C, Wei J, Wang J. Global disease burden of varicella-zoster virus infection: multidimensional analysis and trend projections. J Med Virol. 2025;97(6):e70458.","journal-title":"J Med Virol"},{"key":"1331_CR2","doi-asserted-by":"publisher","first-page":"1535977","DOI":"10.3389\/fpubh.2025.1535977","volume":"13","author":"Z Chang","year":"2025","unstructured":"Chang Z, Li H, Li Y, et al. Comparison of trend analysis of varicella zoster disease burden between China and the world 1990\u20132021 and disease burden forecast 2030. Front Public Health. 2025;13:1535977.","journal-title":"Front Public Health"},{"key":"1331_CR3","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.57187\/s.3962","volume":"155","author":"J Schwidetzky","year":"2025","unstructured":"Schwidetzky J, Heininger U, Salzmann M, Neuhaus TJ, Buettcher M. Clinical outcomes and severe complications of hospitalised children and adolescents with varicella in central Switzerland: a retrospective observational study. Swiss Med Wkly. 2025;155:3962.","journal-title":"Swiss Med Wkly"},{"key":"1331_CR4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2334-9-150","volume":"9","author":"V Baldo","year":"2009","unstructured":"Baldo V, Baldovin T, Russo F, et al. Varicella: epidemiological aspects and vaccination coverage in the Veneto Region. BMC Infect Dis. 2009;9:150.","journal-title":"BMC Infect Dis"},{"key":"1331_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.981220","volume":"12","author":"P Xiao","year":"2022","unstructured":"Xiao P, Cai J, Gao J, et al. A prospective multicenter study on varicella-zoster virus infection in children with acute lymphoblastic leukemia. Front Cell Infect Microbiol. 2022;12:981220.","journal-title":"Front Cell Infect Microbiol"},{"key":"1331_CR6","volume":"32","author":"H Feng","year":"2022","unstructured":"Feng H, Zhang H, Ma C, Zhang H, Yin D, Fang H. National and provincial burden of varicella disease and cost-effectiveness of childhood varicella vaccination in China from 2019 to 2049: a modelling analysis. Lancet Reg Health West Pac. 2022;32:100639.","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"1331_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12916-018-1094-7","volume":"16","author":"A Melegaro","year":"2018","unstructured":"Melegaro A, Marziano V, Del Fava E, et al. The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study. BMC Med. 2018;16(1):117.","journal-title":"BMC Med"},{"issue":"1","key":"1331_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1542\/peds.2013-4251","volume":"134","author":"R Baxter","year":"2014","unstructured":"Baxter R, Tran TN, Ray P, et al. Impact of vaccination on the epidemiology of varicella: 1995\u20132009. Pediatrics. 2014;134(1):24\u201330.","journal-title":"Pediatrics"},{"issue":"2","key":"1331_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1542\/peds.2010-3385","volume":"128","author":"M Marin","year":"2011","unstructured":"Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics. 2011;128(2):214\u201320.","journal-title":"Pediatrics"},{"issue":"10","key":"1331_CR10","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1080\/03007995.2022.2091334","volume":"38","author":"M Pawaskar","year":"2022","unstructured":"Pawaskar M, Kashif SM, Jitender T, Akanksha S, Fergie J. Relative efficacy of varicella vaccines: network meta-analysis of randomized controlled trials. Curr Med Res Opin. 2022;38(10):1772\u201382.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"1331_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","volume":"23","author":"B Kuter","year":"2004","unstructured":"Kuter B, Matthews H, Shinefield H, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J. 2004;23(2):132.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"1331_CR12","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajic.2017.07.029","volume":"46","author":"S Zhu","year":"2018","unstructured":"Zhu S, Zeng F, Xia L, He H, Zhang J. Incidence rate of breakthrough varicella observed in healthy children after 1 or 2 doses of varicella vaccine: results from a meta-analysis. Am J Infect Control. 2018;46(1):e1\u20137.","journal-title":"Am J Infect Control"},{"issue":"25","key":"1331_CR13","first-page":"265","volume":"89","author":"Who","year":"2014","unstructured":"Who. Varicella and herpes zoster vaccines: WHO position paper. PLoS One. 2014;89(25):265\u201387.","journal-title":"PLoS One"},{"key":"1331_CR14","unstructured":"World Health Organization. Introduction of varicella vaccine. https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/introduction-of-varicella-vaccine?ISO_3_CODE=&YEAR=. Accessed 5 Aug 2025."},{"issue":"6","key":"1331_CR15","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/pch\/pxy096","volume":"23","author":"NA Bridger","year":"2018","unstructured":"Bridger NA. School, child care and camp exclusion policies for chickenpox: a rational approach. Paediatr Child Health. 2018;23(6):420\u20137.","journal-title":"Paediatr Child Health"},{"issue":"11","key":"1331_CR16","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1097\/INF.0000000000000444","volume":"33","author":"CA Thomas","year":"2014","unstructured":"Thomas CA, Shwe T, Bixler D, et al. Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students. Pediatr Infect Dis J. 2014;33(11):1164\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"1331_CR17","doi-asserted-by":"crossref","unstructured":"Rieck T, Feig M, An Der Heiden M, Siedler A, Wichmann O. Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015. Euro Surveill. 2017;22(17):30521.","DOI":"10.2807\/1560-7917.ES.2017.22.17.30521"},{"issue":"Suppl 2","key":"1331_CR18","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.1086\/522157","volume":"197","author":"KK Macartney","year":"2008","unstructured":"Macartney KK, Burgess MA. Varicella vaccination in Australia and New Zealand. J Infect Dis. 2008;197(Suppl 2):S191\u20135.","journal-title":"J Infect Dis"},{"issue":"1","key":"1331_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2025.2467773","volume":"14","author":"D Yu","year":"2025","unstructured":"Yu D, Su W, Fan M, et al. Paediatric varicella epidemiology in urban Beijing, China, 2014\u20132023. Emerg Microbes Infect. 2025;14(1):2467773.","journal-title":"Emerg Microbes Infect"},{"issue":"12","key":"1331_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.46005","volume":"5","author":"H Zhang","year":"2022","unstructured":"Zhang H, Lai X, Mak J, et al. Coverage and equity of childhood vaccines in China. JAMA Netw Open. 2022;5(12):e2246005.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1331_CR21","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1186\/s12889-023-16304-4","volume":"23","author":"L Qiu","year":"2023","unstructured":"Qiu L, Liu S, Zhang M, et al. The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance study. BMC Public Health. 2023;23(1):1875.","journal-title":"BMC Public Health"},{"issue":"28","key":"1331_CR22","doi-asserted-by":"publisher","first-page":"45612","DOI":"10.18632\/oncotarget.17317","volume":"8","author":"C Yue","year":"2017","unstructured":"Yue C, Li Y, Wang Y, et al. The varicella vaccination pattern among children under 5\u00a0years old in selected areas in China. Oncotarget. 2017;8(28):45612\u20138.","journal-title":"Oncotarget"},{"issue":"18","key":"1331_CR23","doi-asserted-by":"publisher","first-page":"390","DOI":"10.46234\/ccdcw2024.076","volume":"6","author":"G Luan","year":"2024","unstructured":"Luan G, Yao H, Yin D, Liu J. Trends and age-period-cohort effect on incidence of varicella under age 35 \u2014 China, 2005\u20132021. China CDC Wkly. 2024;6(18):390\u20135.","journal-title":"China CDC Wkly"},{"issue":"6","key":"1331_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2114255","volume":"18","author":"X Sun","year":"2022","unstructured":"Sun X, Zhu Y, Sun H, Xu Y, Zhang L, Wang Z. Comparison of varicella outbreaks in schools in China during different vaccination periods. Hum Vaccin Immunother. 2022;18(6):2114255.","journal-title":"Hum Vaccin Immunother"},{"key":"1331_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1320407","volume":"12","author":"Y Li","year":"2024","unstructured":"Li Y, Xu F, Liu M, Teng S, Liang F, Wang F. Effectiveness of two-dose vs. one-dose varicella vaccine in children in Shanghai, China: a prospective cohort study. Front Public Health. 2024;12:1320407.","journal-title":"Front Public Health"},{"issue":"7","key":"1331_CR26","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.cmi.2018.11.013","volume":"25","author":"Q Wu","year":"2019","unstructured":"Wu Q, Liu J, Wang Y, et al. Effectiveness of second-dose varicella vaccination as post-exposure prophylaxis: a prospective cohort study. Clin Microbiol Infect. 2019;25(7):872\u20137.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"1331_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2025.105049","volume":"55","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Ren Z, Hu P, et al. Assessing the effectiveness of the varicella vaccine in primary and secondary school students in Qingdao, China: a matched case\u2013control study. Infect Dis Now. 2025;55(3):105049.","journal-title":"Infect Dis Now"},{"issue":"19","key":"1331_CR28","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1016\/j.vaccine.2024.05.006","volume":"42","author":"F Liu","year":"2024","unstructured":"Liu F, Li Z, Wang H, et al. Effectiveness of the varicella vaccine in the real world, a matched case-control study. Vaccine. 2024;42(19):3968\u201373.","journal-title":"Vaccine"},{"key":"1331_CR29","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268823001152","volume":"151","author":"S Xiu","year":"2023","unstructured":"Xiu S, Wang X, Wang Q, Jin H, Shen Y. Impact of implementing a free varicella vaccination policy on incidence in Wuxi City, China: an interrupted time series analysis. Epidemiol Infect. 2023;151:e125.","journal-title":"Epidemiol Infect"},{"issue":"2","key":"1331_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jclinepi.2014.06.021","volume":"68","author":"E Moscoe","year":"2015","unstructured":"Moscoe E, Bor J, B\u00e4rnighausen T. Regression discontinuity designs are underutilized in medicine, epidemiology, and public health: a review of current and best practice. J Clin Epidemiol. 2015;68(2):132\u201343.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1331_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev-publhealth-040617-013507","volume":"39","author":"C Wing","year":"2018","unstructured":"Wing C, Simon K, Bello-Gomez RA. Designing difference in difference studies: best practices for public health policy research. Annu Rev Public Health. 2018;39(1):453\u201369.","journal-title":"Annu Rev Public Health"},{"issue":"1","key":"1331_CR32","first-page":"348","volume":"46","author":"JL Bernal","year":"2017","unstructured":"Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348\u201355.","journal-title":"Int J Epidemiol"},{"key":"1331_CR33","unstructured":"National Disease Control and Prevention Administration. Press conference with the theme of \u201cvaccination: safeguarding the entire life cycle\u201d. https:\/\/www.ndcpa.gov.cn\/jbkzzx\/c100009\/common\/content\/content_1914529141938884608.html. Accessed 7 Aug 2025."},{"key":"1331_CR34","unstructured":"Zhang Y. Shen Honhong, director of the National Disease Control and Prevention Administration: China will gradually narrow the gap between its domestic immunization program and international standards. https:\/\/www.thepaper.cn\/newsDetail_forward_30698680. Accessed 7 Aug 2025."},{"issue":"5","key":"1331_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177514","volume":"12","author":"X Tang","year":"2017","unstructured":"Tang X, Zhao S, Chiu APY, et al. Modelling the transmission and control strategies of varicella among school children in Shenzhen, China. PLoS One. 2017;12(5):e0177514.","journal-title":"PLoS One"},{"issue":"1","key":"1331_CR36","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2364485","volume":"20","author":"Z Wang","year":"2024","unstructured":"Wang Z, Chen L, Lu F, et al. Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao\u2019an District of Shenzhen, China. Hum Vaccin Immunother. 2024;20(1):2364485.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"1331_CR37","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jeconom.2020.12.001","volume":"225","author":"B Callaway","year":"2021","unstructured":"Callaway B, Sant\u2019Anna PHC. Difference-in-differences with multiple time periods. J Econom. 2021;225(2):200\u201330.","journal-title":"J Econom"},{"issue":"1","key":"1331_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/1468-0262.00183","volume":"69","author":"J Hahn","year":"2001","unstructured":"Hahn J, Todd P, Van der Klaauw W. Identification and estimation of treatment effects with a regression-discontinuity design. Econometrica. 2001;69(1):201\u20139.","journal-title":"Econometrica"},{"issue":"3","key":"1331_CR39","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1037\/0033-2909.118.3.392","volume":"118","author":"W Gardner","year":"1995","unstructured":"Gardner W, Mulvey EP, Shaw EC. Regression analyses of counts and rates: poisson, overdispersed poisson, and negative binomial models. Psychol Bull. 1995;118(3):392\u2013404.","journal-title":"Psychol Bull"},{"issue":"6","key":"1331_CR40","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/aje\/kwz043","volume":"188","author":"NE Basta","year":"2019","unstructured":"Basta NE, Halloran ME. Evaluating the effectiveness of vaccines using a regression discontinuity design. Am J Epidemiol. 2019;188(6):987\u201390.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"1331_CR41","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jeconom.2007.05.001","volume":"142","author":"GW Imbens","year":"2008","unstructured":"Imbens GW, Lemieux T. Regression discontinuity designs: a guide to practice. J Econometrics. 2008;142(2):615\u201335.","journal-title":"J Econometrics"},{"issue":"2","key":"1331_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1257\/jel.48.2.281","volume":"48","author":"DS Lee","year":"2010","unstructured":"Lee DS, Lemieux T. Regression discontinuity designs in economics. J Econ Lit. 2010;48(2):281\u2013355.","journal-title":"J Econ Lit"},{"issue":"1","key":"1331_CR43","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/14760584.2025.2476524","volume":"24","author":"X Huang","year":"2025","unstructured":"Huang X, Jialing L, Yihan L, et al. The protective effects of two varicella vaccination strategies: a Bayesian modeling study in two megacities in South China. Expert Rev Vaccines. 2025;24(1):212\u201320.","journal-title":"Expert Rev Vaccines"},{"issue":"37","key":"1331_CR44","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.1016\/j.vaccine.2017.07.090","volume":"35","author":"F Hattori","year":"2017","unstructured":"Hattori F, Miura H, Sugata K, et al. Evaluating the effectiveness of the universal immunization program against varicella in Japanese children. Vaccine. 2017;35(37):4936\u201341.","journal-title":"Vaccine"},{"issue":"4","key":"1331_CR45","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-2802","volume":"137","author":"D Perella","year":"2016","unstructured":"Perella D, Wang C, Civen R, et al. Varicella vaccine effectiveness in preventing community transmission in the 2-dose era. Pediatrics. 2016;137(4):e20152802.","journal-title":"Pediatrics"},{"issue":"6","key":"1331_CR46","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/jvh.12359","volume":"22","author":"JN Wu","year":"2015","unstructured":"Wu JN, Wen XZ, Zhou Y, Lin D, Zhang SY, Yan YS. Impact of the free-vaccine policy on timely initiation and completion of hepatitis\u00a0B vaccination in Fujian, China. J Viral Hepat. 2015;22(6):551\u201360.","journal-title":"J Viral Hepat"},{"issue":"7","key":"1331_CR47","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1017\/S0950268814002222","volume":"143","author":"Z Gao","year":"2015","unstructured":"Gao Z, Wood JG, Gidding HF, et al. Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future. Epidemiol Infect. 2015;143(7):1467\u201376.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"1331_CR48","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12874-021-01224-x","volume":"21","author":"F de Vocht","year":"2021","unstructured":"de Vocht F, Katikireddi SV, McQuire C, Tilling K, Hickman M, Craig P. Conceptualising natural and quasi experiments in public health. BMC Med Res Methodol. 2021;21(1):32.","journal-title":"BMC Med Res Methodol"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01331-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01331-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01331-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:02:46Z","timestamp":1777489366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01331-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01331-6","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Huiqiao Gu, Xu Xie, Qiuying Lv, Yuantian Cui, Ziyan Lu, Zaure Akhmetova, Zarina Shulgau, Fang Huang & Yawen Jiang have declared that no competing interests exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was approved by the Ethics Review Committee of the School of Public Health (Shenzhen), Sun Yat-sen University (Approval No. 2023(064)). The data used in this study were fully anonymized, and the requirement for informed consent was waived by the ethics committee because of the retrospective nature of the study. This study is a retrospective analysis based on existing administrative immunization and disease surveillance data. Patients or the public were not involved in the design, conduct, reporting, or dissemination plans of this research. The code used in this study is available from the corresponding authors upon reasonable requests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}